Assignee
SEARLE LLC
US·18 granted patents·12 pending applications·162 citations·filing 1995–2008
Top patents by PatentIndex Score
30 records- 0194US7320983B2α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE LLC·Filed 2006·Granted Jan 22, 2008·8 cites·16 claims
- 0291US7829564B2α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE LLC·Filed 2007·Granted Nov 9, 2010·4 cites·16 claims
- 0390US7339078B2Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitorsSEARLE LLC·Filed 2006·Granted Mar 4, 2008·6 cites·18 claims
- 0488US7531538B2α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE LLC·Filed 2006·Granted May 12, 2009·6 cites·19 claims
- 0586US6740663B2Mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptakeSEARLE LLC·Filed 2002·Granted May 25, 2004·24 cites·150 claims
- 0686US6586434B2Method for the preparation of tetrahydrobenzothiepinesSEARLE LLC·Filed 2001·Granted Jul 1, 2003·16 cites·32 claims
- 0785US7226932B2Self-emulsifying drug delivery systemSEARLE LLC·Filed 2003·Granted Jun 5, 2007·28 cites·13 claims
- 0878USRE42889Eα- and β- amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE LLC·Filed 2007·Granted Nov 1, 2011·2 cites·25 claims
- 0977US6458851B1Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indicationsSEARLE LLC·Filed 1999·Granted Oct 1, 2002·35 cites·8 claims
- 1071US7157101B2Micronized eplerenone compositionsSEARLE LLC·Filed 2004·Granted Jan 2, 2007·3 cites·38 claims
- 1168US2008118969A1Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitorsSEARLE LLC·Filed 2008·Application pending·0 cites
- 1265US2008176842A1Bis-sulfonamide hydroxyethylamino retroviral protease inhibitorsSEARLE LLC·Filed 2007·Application pending·0 cites
- 1363US7297793B2Bis-sulfonamide hydroxyethylamino retroviral protease inhibitorsSEARLE LLC·Filed 2006·Granted Nov 20, 2007·0 cites·20 claims
- 1463US6890958B2Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indicationsSEARLE LLC·Filed 2002·Granted May 10, 2005·1 cites·9 claims
- 1561US7022672B2Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitorSEARLE LLC·Filed 2001·Granted Apr 4, 2006·1 cites·85 claims
- 1659US2004110761A1Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disordersSEARLE LLC·Filed 2003·Application pending·0 cites
- 1754US7012094B1Substituted furans and furanones for the treatment of inflammationSEARLE LLC·Filed 1995·Granted Mar 14, 2006·11 cites·12 claims
- 1851US2004176438A1Novel mono- and di-fluorinated beozothiepine copmunds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptakeSEARLE LLC·Filed 2003·Application pending·0 cites
- 1950US2004028644A1Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indicationsSEARLE LLC·Filed 2003·Application pending·0 cites
- 2049US2004048846A1Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indicationsSEARLE LLC·Filed 2003·Application pending·0 cites
- 2149US2004082647A1Method for the preparation of tetrahydrobenzothiepinesSEARLE LLC·Filed 2003·Application pending·0 cites
- 2248US6489366B1Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indicationsSEARLE LLC·Filed 1999·Granted Dec 3, 2002·6 cites·7 claims
- 2348US6458850B1Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indicationsSEARLE LLC·Filed 1999·Granted Oct 1, 2002·6 cites·12 claims
- 2448US2003166720A1Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indicationsSEARLE LLC·Filed 2002·Application pending·0 cites
- 2547US2003203892A1Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indicationsSEARLE LLC·Filed 2002·Application pending·0 cites
- 2644US6569905B1Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indicationsSEARLE LLC·Filed 1999·Granted May 27, 2003·4 cites·10 claims
- 2742US2003125316A1Combinations of lleal bile acid transport inhibitors and nicotinic acid derivatives for cardiovascular indicationsSEARLE LLC·Filed 2002·Application pending·0 cites
- 2839US2004058908A1Combinations for cardiovascular indicationsSEARLE LLC·Filed 2002·Application pending·0 cites
- 2938US2003199515A1Method for the preparation of crystalline tetrahydrobenzothiepinesSEARLE LLC·Filed 2002·Application pending·0 cites
- 3034US6638969B1Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indicationsSEARLE LLC·Filed 1999·Granted Oct 28, 2003·1 cites·13 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →